Patents by Inventor Calvin Ross
Calvin Ross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20190290576Abstract: The invention provides pharmaceutical compositions for the treatment and prophylaxis of malaria, comprising artemether and a medium chain triglyceride formulated for transmucosal sublingual, buccal or nasal delivery, especially by a spray. Also provided are delivery devices containing the compositions.Type: ApplicationFiled: June 3, 2019Publication date: September 26, 2019Applicant: Protopharma LimitedInventors: Clive Booles, Calvin Ross, Martin Sams
-
Publication number: 20180071207Abstract: The invention provides pharmaceutical compositions for the treatment and prophylaxis of malaria, comprising artemether and a medium chain triglyceride formulated for transmucosal sublingual, buccal or nasal delivery, especially by a spray. Also provided are delivery devices containing the compositions.Type: ApplicationFiled: November 20, 2017Publication date: March 15, 2018Applicant: Protopharma LimitedInventors: Clive Booles, Calvin Ross, Martin Sams
-
Patent number: 9283580Abstract: Disclosed herein are water spray wands comprising an internal water pipe; a spray handle; a compartment for a battery; and a light.Type: GrantFiled: January 17, 2014Date of Patent: March 15, 2016Inventor: Calvin Ross Isley
-
Publication number: 20160038404Abstract: The invention provides pharmaceutical compositions for the treatment and prophylaxis of malaria, comprising artemether and a medium chain triglyceride formulated for transmucosal sublingual, buccal or nasal delivery, especially by a spray. Also provided are delivery devices containing the compositions.Type: ApplicationFiled: July 24, 2015Publication date: February 11, 2016Applicant: Protopharma LimitedInventors: Clive Booles, Calvin Ross, Martin Sams
-
Publication number: 20150202642Abstract: Disclosed herein are water spray wands comprising an internal water pipe; a spray handle; a compartment for a battery; and a light.Type: ApplicationFiled: January 17, 2014Publication date: July 23, 2015Inventor: Calvin Ross ISLEY
-
Publication number: 20140179772Abstract: The invention provides pharmaceutical compositions for the treatment and prophylaxis of malaria, comprising artemether and a medium chain triglyceride formulated for transmucosal sublingual, buccal or nasal delivery, especially by a spray. Also provided are delivery devices containing the compositions.Type: ApplicationFiled: July 26, 2013Publication date: June 26, 2014Applicant: Protopharma LimitedInventors: Clive Booles, Calvin Ross, Martin Sams
-
Patent number: 8512767Abstract: The present invention relates to an improved mode of administration for cannabis and its natural and synthetic derivatives. A pharmaceutical composition suitable for sublingual aerosol or spray delivery of cannabis is provided. The formulation may be dispensed using a pump spray or the formulation may include a propellant, such as butane, 1,1,1,2-tetrafluoroethane (HFC-134a) or 1,1,1,2,3,3,3-heptafluoropropane (HFC-227). The term cannabis is used herein to refer to all physiologically active substances derived from the cannabis family of plants and synthetic cannabis analogues and derivatives, precursors, metabolites etc., or related substances having cannabis-like physiological effects.Type: GrantFiled: September 7, 2012Date of Patent: August 20, 2013Assignee: GW Pharma LimitedInventor: Calvin Ross
-
Patent number: 8481091Abstract: The present invention relates to an improved mode of administration for cannabis and its natural and synthetic derivatives. A pharmaceutical composition suitable for sublingual aerosol or spray delivery of cannabis is provided. The formulation may be dispensed using a pump spray or the formulation may include a propellant, such as butane, 1,1,1,2-tetrafluoroethane (HFC-134a) or 1,1,1,2,3,3,3-heptafluoropropane (HFC-227). The term cannabis is used herein to refer to all physiologically active substances derived from the cannabis family of plants and synthetic cannabis analogues and derivatives, precursors, metabolites etc., or related substances having cannabis-like physiological effects.Type: GrantFiled: September 10, 2012Date of Patent: July 9, 2013Assignee: GW Pharma LimitedInventor: Calvin Ross
-
Publication number: 20130006182Abstract: The present invention relates to an improved mode of administration for cannabis and its natural and synthetic derivatives. A pharmaceutical composition suitable for sublingual aerosol or spray delivery of cannabis is provided. The formulation may be dispensed using a pump spray or the formulation may include a propellant, such as butane, 1,1,1,2-tetrafluoroethane (HFC-134a) or 1,1,1,2,3,3,3-heptafluoropropane (HFC-227). The term cannabis is used herein to refer to all physiologically active substances derived from the cannabis family of plants and synthetic cannabis analogues and derivatives, precursors, metabolites etc., or related substances having cannabis-like physiological effects.Type: ApplicationFiled: September 7, 2012Publication date: January 3, 2013Applicant: GW Pharma LimitedInventor: Calvin Ross
-
Publication number: 20120328718Abstract: The present invention relates to an improved mode of administration for cannabis and its natural and synthetic derivatives. A pharmaceutical composition suitable for sublingual aerosol or spray delivery of cannabis is provided. The formulation may be dispensed using a pump spray or the formulation may include a propellant, such as butane, 1,1,1,2-tetrafluoroethane (HFC-134a) or 1,1,1,2,3,3,3-heptafluoropropane (HFC-227). The term cannabis is used herein to refer to all physiologically active substances derived from the cannabis family of plants and synthetic cannabis analogues and derivatives, precursors, metabolites etc., or related substances having cannabis-like physiological effects.Type: ApplicationFiled: September 10, 2012Publication date: December 27, 2012Applicant: GW Pharma LimitedInventor: Calvin Ross
-
Publication number: 20110015260Abstract: The invention provides pharmaceutical compositions for the treatment and prophylaxis of malaria, comprising artemether and a medium chain triglyceride formulated for transmucosal sublingual, buccal or nasal delivery, especially by a spray. Also provided are delivery devices containing the compositions.Type: ApplicationFiled: October 27, 2008Publication date: January 20, 2011Applicant: PROTOPHARMA LIMITEDInventors: Clive Booles, Calvin Ross, Martin Sams
-
Publication number: 20100323038Abstract: The present invention relates to an improved mode of administration for cannabis and its natural and synthetic derivatives. A pharmaceutical composition suitable for sublingual aerosol or spray delivery of cannabis is provided. The formulation may be dispensed using a pump spray or the formulation may include a propellant, such as butane, 1,1,1,2-tetrafluoroethane (HFC-134a) or 1,1,1,2,3,3,3-heptafluoropropane (HFC-227). The term cannabis is used herein to refer to all physiologically active substances derived from the cannabis family of plants and synthetic cannabis analogues and derivatives, precursors, metabolites etc., or related substances having cannabis-like physiological effects.Type: ApplicationFiled: August 10, 2010Publication date: December 23, 2010Applicant: GW Pharma LimitedInventor: Calvin Ross
-
Publication number: 20080071233Abstract: The present invention relates to an improved mode of administration for cannabis and its natural and synthetic derivatives. A pharmaceutical composition suitable for sublingual aerosol or spray delivery of cannabis is provided. The formulation may be dispensed using a pump spray or the formulation may include a propellant, such as butane, 1,1,1,2-tetrafluoroethane (HFC-134a) or 1,1,1,2,3,3,3-heptafluoropropane (HFC-227). The term cannabis is used herein to refer to all physiologically active substances derived from the cannabis family of plants and synthetic cannabis analogues and derivatives, precursors, metabolites etc., or related substances having cannabis-like physiological effects.Type: ApplicationFiled: September 18, 2007Publication date: March 20, 2008Applicant: GW Pharma LimitedInventor: Calvin Ross
-
Publication number: 20060191532Abstract: The present invention relates to dispensing devices and in particular to spray devices which are used to dispense pharmaceutical compositions in a controlled and safe manner.Type: ApplicationFiled: March 11, 2004Publication date: August 31, 2006Inventor: Calvin Ross
-
Publication number: 20060062812Abstract: Compositions and method are provided, for the treatment of pain, e.g. acute breakthrough pain, by means of a systemic, non-invasive mode of administration. Specifically, the invention relates to a sublingual presentation of an opioid analgesic, such as fentanyl, or its salts, in amounts that are sufficient to treat the pain.Type: ApplicationFiled: September 12, 2005Publication date: March 23, 2006Inventors: Calvin Ross, Clive Booles, Alistair Campbell, Paul Woodcock, Scott Davis
-
Publication number: 20030191180Abstract: The present invention relates to an improved mode of administration for cannabis and its natural and synthetic derivatives. A pharmaceutical composition suitable for sublingual aerosol or spray delivery of cannabis is provided. The formulation may be dispensed using a pump spray or the formulation may include a propellant, such as butane, 1,1,1,2-tetrafuorethane (HFC-134a) or 1,1,1,2,3,3,3-heptafluropropane (HFC-227). The term cannabis is used herein to refer to all physiologically active substances derived from the cannabis family of plants and synthetic cannabis analogues and derivatives, precursors, metabolites etc., or related substances having cannabis-like physiological effects.Type: ApplicationFiled: May 6, 2003Publication date: October 9, 2003Inventor: Calvin Ross
-
Publication number: 20030190290Abstract: The present invention relates to compositions and dispensing devices for improved administration of fentanyl and other opioid analgesics, such as alfentanil, carfentanil, remifentanil, sufentanil, buprenorphine, morphine, diamorphine, and the like.Type: ApplicationFiled: May 28, 2003Publication date: October 9, 2003Inventor: Calvin Ross